Evidence map›Paper›PMID 38754428›Full record

ArticleCell stem cell2024

Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells.

Paul V Dellorusso, Melissa A Proven, Fernando J Calero-Nieto, Xiaonan Wang, Carl A Mitchell, Felix Hartmann, Meelad Amouzgar, Patricia Favaro, Andrew DeVilbiss, James W Swann and 6 more

Abstract read
In one paragraph

Article in Cell stem cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Hematopoietic Stem Cell Metabolism during Stress and Aging.Advances in geriatric medicine and research · 2026
    Article
  3. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Hematopoietic Aging and Leukemia: Mechanistic and Therapeutic Insights.International journal of molecular sciences · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Ageing, immune fitness and cancer.Nature reviews. Cancer · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Paul V DellorussoColumbia Stem Cell Initiative, Department of Genetics & Development, Columbia University, New York, NY 10032, USA.
Melissa A ProvenColumbia Stem Cell Initiative, Department of Genetics & Development, Columbia University, New York, NY 10032, USA.
Fernando J Calero-NietoWelcome and MRC Cambridge Stem Cell Institute, Department of Haematology, Cambridge University, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
Xiaonan WangWelcome and MRC Cambridge Stem Cell Institute, Department of Haematology, Cambridge University, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
Carl A MitchellColumbia Stem Cell Initiative, Department of Genetics & Development, Columbia University, New York, NY 10032, USA.
Felix HartmannDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Meelad AmouzgarDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Patricia FavaroDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Andrew DeVilbissChildren's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
James W SwannColumbia Stem Cell Initiative, Department of Genetics & Development, Columbia University, New York, NY 10032, USA.
Theodore T HoEli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA 94143, USA.
Zhiyu ZhaoChildren's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sean C BendallDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sean MorrisonChildren's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Berthold GöttgensWelcome and MRC Cambridge Stem Cell Institute, Department of Haematology, Cambridge University, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
Emmanuelle PasseguéColumbia Stem Cell Initiative, Department of Genetics & Development, Columbia University, New York, NY 10032, USA. Electronic address: ep2828@cumc.columbia.edu.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Emergency Myelopoiesis Pathways in the Control of Blood ProductionR35HL135763 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PASSEGUE, EMMANUELLE · 2017 to 2023
$5.7M
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)TL1DK136048 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI JONATHAN M. BARASCH, Wadie F Bahou · 2022 to 2026
$3.8M
Mechanisms of Hematopoietic Stem Cell and Blood agingR01AG073599 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PASSEGUE, EMMANUELLE · 2021 to 2025
$2.5M
Replication Stress and Ribosome Biogenesis in Hematopoietic Stem Cell AgingF31HL160207 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MITCHELL, CARL · 2021 to 2023
$136k
Autophagy Engagement and Hematopoietic Stem Cell Maintenance During AgingF31HL151140 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DELLORUSSO, PAUL VINCENT · 2020 to 2021
$90k
Cancer Research UK 21762Medical Research Council MC_PC_17230NCI NIH HHS P30 CA013696NHLBI NIH HHS F31 HL151140NHLBI NIH HHS F31 HL160207NHLBI NIH HHS R35 HL135763NIA NIH HHS R01 AG073599NIDDK NIH HHS TL1 DK136048Wellcome Trust
6 · The paper itself

Abstract

Autophagy is central to the benefits of longevity signaling programs and to hematopoietic stem cell (HSC) response to nutrient stress. With age, a subset of HSCs increases autophagy flux and preserves regenerative capacity, but the signals triggering autophagy and maintaining the functionality of autophagy-activated old HSCs (oHSCs) remain unknown. Here, we demonstrate that autophagy is an adaptive cytoprotective response to chronic inflammation in the aging murine bone marrow (BM) niche. We find that inflammation impairs glucose uptake and suppresses glycolysis in oHSCs through Socs3-mediated inhibition of AKT/FoxO-dependent signaling, with inflammation-mediated autophagy engagement preserving functional quiescence by enabling metabolic adaptation to glycolytic impairment. Moreover, we show that transient autophagy induction via a short-term fasting/refeeding paradigm normalizes glycolytic flux and significantly boosts oHSC regenerative potential. Our results identify inflammation-driven glucose hypometabolism as a key driver of HSC dysfunction with age and establish autophagy as a targetable node to reset oHSC regenerative capacity.

Indexed as

AutophagyGlycolysisHematopoietic Stem CellsInflammationAgingAnimalsCellular SenescenceGlucoseMiceMice, Inbred C57BLSignal TransductionSuppressor of Cytokine Signaling 3 ProteinGlucoseSuppressor of Cytokine Signaling 3 Proteinagingautophagyhematopoietic stem cellsinflammationmetabolismregeneration

Identifiers

PMID38754428
PMCPMC11350610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.